Importance of Glycobiology in Biomembrane Research |
| K. Nitta |
| J. Pharm. Soc. Jpn., 127(4),551-552, 2007 |
|
Regulation of Globotriaosylceramide (Gb3)-mediated Signal Transduction by Rhamnose-binding Lectin |
| K. Nitta, T. Kawano, S. Sugawara, and M. Hosono |
| J. Pharm. Soc. Jpn., 127(4),553-561, 2007 |
|
Regulation of Neuronal Cell Function by Glyco-signals |
| H. Higashi |
| J. Pharm. Soc. Jpn., 127(4),563-570, 2007 |
|
Regulation of Integrin Functions by N-glycans |
| J. Gu |
| J. Pharm. Soc. Jpn., 127(4),571-578, 2007 |
|
Insulin Resistance as a Membrane Microdomain Disorder |
| J. Inokuchi |
| J. Pharm. Soc. Jpn., 127(4),579-586, 2007 |
|
Improvement of Gastrointestinal and Transmucosal Absorption of Drugs |
| A. Yamamoto |
| J. Pharm. Soc. Jpn., 127(4),587-587, 2007 |
|
Safe Improvement of Drug Absorption by Combinatorial Use of Sodium Laurate with Amino Acids: Cytoprotection by Amino Acids and Its Mechanisms |
| K. Higaki |
| J. Pharm. Soc. Jpn., 127(4),589-599, 2007 |
|
Barriology-based Strategy for Drug Absorption |
| M. Kondoh, M. Fujii, K. Yagi, and Y. Watanabe |
| J. Pharm. Soc. Jpn., 127(4),601-609, 2007 |
|
Hydrolysis by Carboxylesterase and Disposition of Prodrug with Ester Moiety |
| T. Imai |
| J. Pharm. Soc. Jpn., 127(4),611-619, 2007 |
|
Study on the Colon Specific Delivery of Prednisolone Using Chitosan Capsules |
| A. Yamamoto |
| J. Pharm. Soc. Jpn., 127(4),621-630, 2007 |
|
Control of Pulmonary Absorption of Drugs by Various Pharmaceutical Excipients |
| K. Yamada |
| J. Pharm. Soc. Jpn., 127(4),631-641, 2007 |
|
Local and Systemic Delivery of High-Molecular Weight Drugs by Powder Inhalation |
| H. Okamoto and K. Danjo |
| J. Pharm. Soc. Jpn., 127(4),643-653, 2007 |
|
The Recent Trend of Transdermal Drug Delivery System Development |
| N. Higo |
| J. Pharm. Soc. Jpn., 127(4),655-662, 2007 |
|
Stress Responses via Metallothioneins: Roles in the Biological Defense Mechanism |
| S. Koizumi |
| J. Pharm. Soc. Jpn., 127(4),663-664, 2007 |
|
Heavy Metal Responses of the Human Metallothionein Isoform Genes |
| N. Miura and S. Koizumi |
| J. Pharm. Soc. Jpn., 127(4),665-673, 2007 |
|
Mechanism of Metallothionein Gene Activation Mediated by Heavy-metal Dependent Transcription Factor MTF-1 |
| F. Otsuka, S. Ohno, K. Suzuki, K. Takahashi, M. Ohsawa, and S. Koizumi |
| J. Pharm. Soc. Jpn., 127(4),675-684, 2007 |
|
Cytokine-induced Metallothionein Expression and Modulation of Cytokine Expression by Metallothionein |
| N. Itoh and T. Kimura |
| J. Pharm. Soc. Jpn., 127(4),685-694, 2007 |
|
The Physiological Significance of Metallothionein in Oxidative Stress |
| K.-S. Min |
| J. Pharm. Soc. Jpn., 127(4),695-702, 2007 |
|
Endoplasmic Reticulum Stress and Metallothionein |
| M. Sato and S. Suzuki |
| J. Pharm. Soc. Jpn., 127(4),703-708, 2007 |
|
Analysis of Toxicity Using Metallothionein Knockout Mice |
| M. Satoh |
| J. Pharm. Soc. Jpn., 127(4),709-717, 2007 |
|
New Development of Individual Pharmacology Aiming Drug Creation in Pharmaceutical Science |
| Y. Iwatani |
| J. Pharm. Soc. Jpn., 127(4),719-719, 2007 |
|
A Study for an Allergic Inflammation Model Using Human Lungs and Its Pharmacological Application |
| H. Hama, N. Ono, and M. Abe |
| J. Pharm. Soc. Jpn., 127(4),721-727, 2007 |
|
Mechanisms Underlying Enhanced Vasodilator Responses to Various Vasodilator Agents following Endothelium Removal in Rat Mesenteric Resistance Arteries |
| Y. Iwatani, H. Numa, S. Atagi, F. Takayama, M. Mio, and H. Kawasaki |
| J. Pharm. Soc. Jpn., 127(4),729-733, 2007 |
|
Strategy to Develop a New Drug for Treatment-resistant Depression-Role of Electroconvulsive Stimuli and BDNF- |
| B. Li, K. Suemaru, Y. Kitamura, R. Cui, Y. Gomita, and H. Araki |
| J. Pharm. Soc. Jpn., 127(4),735-742, 2007 |
|
Brain Embolism-induced Injury of Vascular Endothelial Cells and a Novel Vasoprotective Drug |
| F. Han and K. Fukunaga |
| J. Pharm. Soc. Jpn., 127(4),743-748, 2007 |
|